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Abstract Applying an RNA display strategy to identify genes 
of autocrine activated endothelial cells, we identified among 
others the Ras-related protein TC21/R-Ras2 as a differentially 
expressed gene of bovine aortic endothelial cells (BAEC). 
Migrating BAEC express prominently upregnlated steady state 
levels of TC21/R-Ras2 mRNA (Northern blot, in situ hybridiza- 
tion) and protein (Western blot). Growth factor stimulation 
identified TC21/R-Ras2 as aFGF, bFGF, and EGF inducible 
molecule of BAEC. Exposure to actinomycin D revealed a half 
life time of TC21/R-Ras2 mRNA of > 2 h. These results 
strongly suggest hat transcriptional regulation of Ras molecules 
contributes to their signal transduction capacity and a possible 
role of TC21/R-Ras2 in the signal transduction of autocrine 
activated endothelial cells. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Members of the superfamily of Ras GTPases play critical 
roles as regulators of normal cellular growth, differentiation, 
and development. Acting as molecular switch by cycling be- 
tween that active GTP bound state and the inactive GDP 
bound state, they regulate a plethora of cellular functions 
that range from cellular proliferation (Ras GTPases), cyto- 
skeletal organization (Rac/Rho GTPases), vesicle trafficking 
(ARF and Rab GTPases), and nuclear transport (Ran 
GYPases) [1]. 
The activity of Ras proteins is controlled by guanine nu- 
cleotide xchange factors (GEFs) that catalyze the conversion 
of Ras to the active GTP bound state and by GTPase activat- 
ing proteins (GAPs) that accelerate the hydrolysis of bound 
GTP to GDP [2,3]. Activated Ras binds to multiple proteins 
in a GTP-dependent manner to exert its diverse ffector func- 
tions [4]. Of these, the binding of the ser/thr kinase Raf-1 and 
downstream signaling through the ubiquitous mitogen acti- 
vated protein (MAP) kinase cascade has been studies most 
extensively. 
Despite the enormous progress that has been made in the 
identification of factors that regulate the activity of Ras mol- 
ecules surprisingly little is known about the transcriptional 
regulation of Ras proteins themselves. In an effort to identify 
factors that regulate ffector functions of autocrine activated 
endothelial cells, we analyzed gene expression of quiescent, 
resting and subconfluent, migrating bovine aortic endothelial 
(BAE) cells by differential RNA display [5]. The rationale of 
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the experiments was directed by the hypothesis that the subtle 
difference in growth configuration between subconfluent, mi- 
grating and resting, quiescent endothelial cells reflects some of 
specific properties of angiogenic endothelial cel s in vivo in 
comparison to the phenoytpe of the mature, quiescent vascu- 
lar endothelium. The phenotypic properties of subconfluent 
endothelial cells are under autocrine control and our screen 
consequently led to the identification of follistatin as a differ- 
entially expressed endothelial cell gene that regulates auto- 
crine endothelial cell activity during angiogenesis [6], Among 
other potentially relevant candidate genes that may regulate 
angiogenesis, we identified the Ras-related protein TC21/R- 
Ras2 [7] as a differentially expressed gene of subconfluent, 
migrating BAE cells. Based on this findings we have studied 
the transcriptional regulation of TC21/R-Ras2 in endothelial 
cells, which was found to be exclusively expressed by subcon- 
fluent, migrating not by quiescent, resting BAE cells. Based on 
the established functions of TC21/R-Ras2 in mediating mito- 
genic signal transduction i cluding the possible transforming 
capacity of normal TC21/R-Ras2 upon overexpression [8], 
transcriptional regulation of TC21/R-Ras2 may play an im- 
portant role in the mitogenic signal transduction of autocrine 
activated endothelial cells. 
2. Materials and methods 
2.1. Cytokines, antibodies and reagents 
bFGF, aFGF, TGFI31, and EGF were obtained from Promega 
(Madison, WI). Rabbit polyclonal anti TC21/R-Ras2 antibodies 
were from Santa Cruz Biotechnology (Santa Cruz, CA). DMEM 
and other cell culture media were from Life Technologies (Eggenstein, 
Germany). Fetal bovine serum was obtained from Biochrom (Berlin, 
Germany). 
2.2. Cell culture 
Bovine aortic endothelial (BAE) cells were isolated from thoracic 
aortas of healthy cattle by collagenase digestion following standard 
protocols. Cells were cultured at 37°C in 75 cm 2 tissue culture dishes 
in Dulbecco's modified Eagle medium (DMEM) containing 10% heat
inactivated fetal bovine serum (FBS) and frozen i  liquid nitrogen at 
passage 2 or 3. Cells were routinely split at a 1:5r tio and cultured up 
to 50 passages. Using these culture conditions, subconfluent BAE cells 
express high levels of endogenous bFGF up to passage 20 which will 
then gradually decline to undetectable levels during in vitro senescence 
[9]. Subconfluent migrating BAE cells were harvested at approxi- 
mately 50% confluence 48 h after seeding. Quiescent, postconfluent 
BAE cells were reefed once and harvested three days after growing to 
confluence. 
2.3. Differential RNA display 
A comparative differential RNA display analysis of gene xpression 
of migrating, subeonfluent and quiescent, resting bovine aortic endo- 
thelial cells (BAEC) was performed as described previously [5]. In 
brief, cytoplasmic RNA was reverse transcribed an  the differential 
RNA display PCR was performed for 40 cycles using a 10mer random 
oligonucleotide and a TI IXY 3' anchoring primer. Display products 
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were resolved on a denaturing 6% PAA sequencing gel. Differentially 
expressed fragment cDNAs were excised, reamplified by PCR, cloned 
and sequenced applying standard protocols. 
2.4. RNA isolation and Northern blot analysis 
Cells were washed twice with PBS, harvested with a cell scraper. 
RNA was isolated according to the single step guanidium thiocyanate- 
phenol-chloroform extraction procedure using Trizol (Life Technolo- 
gies, Eggenstein, Germany). For Northern blot analysis of TC21/R- 
Ras2 expression, 20 Ixg of total RNA was electrophoresed through a 
1% agarose gel, capillary transferred onto nylon membranes (Hybond 
N, Amersbam, Germany), and used for hybridization with the ran- 
dom prime labeled TC21/R-Ras2 cDNA probe (DNA labeling kit, 
Pharmacia, Uppsala, Sweden). Hybridization with an 18S rRNA oli- 
gonucleotide was performed to confirm equal oading of the different 
lanes [9]. All Northern blot experiments have at least been performed 
twice with similar results. To avoid any subjective bias that may result 
from unequal loading of different lanes, all Northern blot experiments 
were also analyzed ensitometrically. 
2.5. In situ hybridization 
BAE cells were grown on glass coverslips as either confluent or 
subconfluent ceils. Monolayers were fixed with 4% paraformaldehyde, 
washed, and treated with proteinase K (1 ~tg/ml, 37°C, 15 min). Pre- 
hybridization was carried out for 2 h at 55°C in 0.3 M NaC1, 20 mM 
Tris (pH 7.5), 5 mM EDTA, 1 XDenhardt's olution, 10 mM dithio- 
threitol, and 50% formamide, after which the coverslips were incu- 
bated with 35S-uridine 5' triphosphate (UTP)-labeled sense and anti- 
sense TC21/R-Ras2 probes for 16 h. A 398 bp fragment of the 612 bp 
TC21/R-Ras2 cDNA was cloned in both directions into pCRIII (In- 
vitrogen). Sense and antisense probes were generated with T7 RNA 
polymerase after linearization with EcoRV (Riboprobe System, Prom- 
ega, WI). After hybridization (at 55°C overnight), the specimens were 
washed with 2 x SSC, 10 mM 13-mercaptoethanol, 1 mM EDTA (twice 
for 10 min each), treated with RNase A (20/ag/ml, 30 min, 37°C), and 
washed in 2 x SSC (as above) followed by a high stringency wash at 
55°C for 2 h (0.1XSSC, 10 mM [3-mercaptoethanol, 1 mM EDTA). 
Slides were coated with autoradiographic emulsion (Kodak, NTB2), 
exposed for 3 weeks, and then developed (Kodak, D-19). Slides were 
evaluated and photographed by light microscopy using dark-field and 
bright-field illumination. 
2.6. Western blot analys& 
Cells were washed twice with PBS, harvested with a cell scraper, 
and lysed in a 1% NP40 buffer. Nuclei were removed by centrifnga- 
tion and the lysate was subjected to reducing SDS-polyacrylamide g l
electrophoresis (12% gel). Proteins were transferred to cellulose nitrate 
membranes (Schleicher und Sch~ill, Dassel, Germany) and blocked 
overnight in 2% BSA/PBS. TC21/R-Ras2 protein was detected using 
a polyclonal rabbit anti TC21/R-Ras2 antiserum (0.2 ~g/ml). Bound 
antibody was visualized by incubation with a HRP-labeled anti rabbit 
Ig second antibody (1:5000), which was visualized by chemilumines- 
cent detection (ECL Detection System, Amersham). 
3. Results 
3.1. Autocrine regulated ifferential expression of 
TC21/R-Ras2 in BAE cells 
Comparative Northern blot analysis of migrating, subcon- 
fluent and resting, confluent bovine aortic endothelial (BAE) 
cells identified the Ras-related protein TC21/R-Ras2 as a dif- 
ferentially regulated gene of endothelial cells (Fig. 1A). Sub- 
confluent BAE cells abundantly expressed TC21/R-Ras2 tran- 
scripts. In contrast, TC21/R-Ras2 expression was almost 
completely downregulated in resting confluent BAE cells. 
Cultured BAE cells exhibit a considerable degree of pheno- 
typic heterogeneity. We consequently confirmed the differen- 
tial expression of TC21/R-Ras2 transcripts in BAE cells by in 
situ hybridization to trace expression levels of individual cells. 
These experiments revealed that TC21/R-Ras2 mRNA levels 
were homogeneously upregulated in subconfluent, migrating 
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Fig. 1. Differential expression of the Ras-related molecule TC21/R- 
Ras2 in bovine aortic endothelial (BAE) cells. A: Subconfluent, mi- 
grating BAE cells express prominently upregulated levels of steady 
state TC21/R-Ras2 mRNA levels. Both TC21/R-Ras2 transcripts 
are upregulated with the larger 2.4 kb transcript being most promi- 
nently expressed in migrating BAE cells. B: Western blot analysis 
of migrating and resting BAE cells identifies TC21/R-Ras2 protein 
in migrating and not in resting BAE cells. C: Dark-field and bright- 
field images of in situ hybridization experiments with subconfluent, 
migrating (left) and confluent, resting (right) BAE cells using anti- 
sense (upper panel) and sense (lower panel) TC21/R-Ras2 probes. 
Prominent TC21/R-Ras2 expression is uniformly detectable in sub- 
confluent BAE cells. In contrast, only background hybridization lev- 
els are detectable in confluent BAE cells. 
BAE cells and evenly downregulated in resting confluent BAE 
cells (Fig. 1C). 
Analysis of TC21/R-Ras2 protein expression confirmed the 
differential expression of TC21/R-Ras2 as determined by 
Northern blot and in situ hybridization. TC21/R-Ras2 protein 
was detected in subconfluent and ot in resting monolayers of 
BAE cells (Fig. 1B). 
3.2. Cytokine regulation of endothelial TC21/R-Ras2 
expression 
In the experiments performed so far, TC21/R-Ras2 expres- 
sion in BAE cells was induced under autocrine control by 
releasing the cells from growth arrest. A number of endoge- 
nous growth factors have been implicated in regulating 
growth control f  autocrine activated endothelial cells includ- 
ing the heparin-binding rowth factor bFGF  [10,11]. Stimu- 
lated resting BAE cells with different cytokines revealed that 
aFGF,  bFGF,  and EGF  induced TC21/R-Ras2 expression, 
whereas TGF[31 did not induce TC21/R-Ras2 expression 
(Fig. 2). 
We next determined the time course of TC21/R-Ras2 ex- 
pression following bFGF stimulation. Exposing BAE cells to 
bFGF  for various time periods resulted in maximum TC21/R- 
Ras2 transcripts levels 8 h after the addition of bFGF  (Fig. 3). 
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Fig. 2. Cytokine induction f TC21/R-Ras2 expression in BAE cells. 
Resting BAE cells were stimulated for 4 h with 5 ng/ml aFGF, 
bFGF, TGFI3, and EGF (-,  resting control cells; +, serum stimula- 
tion of resting cells). 
This surprisingly slow response to exogenously added bFGF 
strongly suggests that bFGF does not directly stimulate TC21/ 
R-Ras2 expression. 
3.3. Analysis of TC21/R-Ras2 mRNA stability 
To determine TC21/RoRas2 mRNA half life time in cul- 
tured BAE cells, we exposed subconfluent, migrating TC21/ 
R-Ras2 expressing BAE cells to actinomycin D and deter- 
mined TC21/R-Ras2 transcript levels by Northern blot anal- 
ysis. As shown in Fig. 4, TC21/R-Ras2 transcript levels re- 
main constant for 2 h after the addition of actinomycin D. At 
4 h after actinomycin D treatment, TC21/R-Ras2 transcript 
levels have declined to barely detectable l vels. 
4. Discussion 
Quiescent, resting endothelial cells line the inside of all 
blood vessels forming a structurally and functionally hetero- 
geneous cell population [12]. Mitogenic activation f endothe- 
lial cells in the healthy adult occurs highly restricted and is 
limited to regeneration and repair processes, uch as reendo- 
thelialization and angiogenesis. Angiogenic endothelial cells 
express a distinct repertoire of molecules that enables them 
to perform specific microenvironmental interactions during 
the angiogenic cascade. These include specific adhesive inter- 
actions involving C~v~:3 and (~vJ3~ integrins [13] as well as the 
ligands of endothelial cell specific growth factors such as the 
receptor tyrosine kinases flk-l/KDR and fit-1 [14]. 
Mechanisms of autocrine activation contribute to the an- 
giogenic ascade by further stimulating endothelial cells that 
are initially activated by exogenous growth factors. In order 
to identify growth regulatory mechanisms of autocrine acti- 
vated endothelial cells, we have analyzed gene expression of 
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Fig. 3. Time course of bFGF induced TC21/R-Ras2 expression. 
Resting BAE cells were stimulated with 5 ng/ml bFGF for the time 
periods indicated. Maximum TC21/R-Ras2 expression is detectable 
at 8 h after stimulation. 
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Fig. 4. Analysis of TC21/R-Ras2 transcript stability in BAE cells. 
Subconfluent, migrating BAE cells, expressing hi h levels of TC21/ 
R-Ras2 transcripts, were exposed to actinomycin D for the time pe- 
riods indicated after which cells were harvested for Northern blot 
analysis. TC21/R-Ras2 transcripts levels ar  unchanged for the first 
2 h after actinomycin D exposure. After 4 h of actinomycin D treat- 
ment, TC21/R-Ras2 transcripts are barely detectable (4 (), control 
cell population after 4 h without actinomycin D treatment). 
quiescent, resting and subconfluent, migrating endothelial 
cells by differential RNA display. Among the differentially 
expressed genes of migrating endothelial cells was the Ras- 
related protein TC21/R-Ras2. TC21/R-Ras2 was originally 
identified by homology cloning [7]. It displays 55% amino 
acid homology with p21 r~'. Of the many different Ras mole- 
cules that have been identified in recent years, TC21/R-Ras2 is 
in addition to mutated Ras itself the only Ras family molecule 
that has been shown to exert transforming potential [8,15]. 
Interestingly, recent data even suggest hat not just mutated 
TC21/R-Ras2, but also overexpression f the normal gene is 
capable of inducing neoplastic transformation [8]. These ex- 
periments suggest a similarly critical role of TC21/R-Ras2 as 
of Ras itself in transducing mitogenic signals. Little is known 
about the signal transduction cascade activated by TC21/R- 
Ras2. Experimental evidence suggests that the same upstream 
signals that activate Ras signal transduction also stimulate 
TC21/R-Ras2. In contrast to Ras, however, TC21/R-Ras2 
appears to engage different downstream signaling pathways 
that do not involve Raf [16]. Differences between Ras and 
TC21/R-Ras2 functions are also supported by the observation 
that farnesyltransferase inhibitors act as inhibitors of Ras but 
not of TC21/R-Ras2 [17]. 
Little is known about TC21/R-Ras2 function in vivo. In 
contrast o the ubiquitous expression of Ras proteins. TC21/ 
R-Ras2 protein expression is restricted (high levels in kidney, 
placenta, and ovaries: moderate levels in liver as well as car- 
diac and skeletal muscle: no expression in brain, testes, and 
lung) [16] suggesting that the function of TC21/R-Ras2 may 
be limited to certain tissues and/or cells. We were surprised to 
find a dramatic transcriptional regulation of TC21/R-Ras2 in 
cultured endothelial cells. Quiescent, resting BAE cells ex- 
pressed barely detectable TC21/R-Ras2 mRNA and protein. 
In contrast, activating BAE cells just by releasing them from 
growth arrest resulted in a prominent upregulation of TC21/ 
R-Ras2 mRNA and subsequently protein levels. Growth ['ac- 
tor stimulation identified TC21/R-Ras2 as aFGF, bFGF, and 
EGF inducible gene. The time course of gene expression, how- 
ever, would suggest hat the induction of TC21/R-Ras2 gene 
expression was not a direct growth l`actor mediated early re- 
sponse event. 
Ras molecules are important regulators of endothelial cell 
function. Transfection of SV40 large T antigen expressing 
murine endothelioma cells with oncogenic Ras leads to full 
neoplastic transformation f cells that are capable of forming 
angiosarcomas in vivo [18]. The structurally and functionally 
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related Ras family member TC21/R-Ras2 appears to have 
even higher transformation potential [8,15] and a more limited 
expression pattern in vivo. The observed differential expres- 
sion of TC21/R-Ras2 in autocrine regulated endothelial 
would, thus, suggest hat it may play an important role in 
mediating mitogenic signal transduction of endothelial cells 
during processes of endothelial cell activation, such as angio- 
genesis and reendothelialization. Furthermore, regulation of 
TC21/R-Ras2 expression in endothelial cells may be of more 
general relevance since the transcriptional regulation of Ras 
molecules has received little attention so far despite the fact 
that this may be an important regulator of Ras molecule 
function. 
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